FamGenix provides a platform that connects patients with healthcare providers to evaluate the risk of hereditary diseases through genetic testing and family history analysis. This service enables individuals to gain insights into their genetic predispositions, facilitating informed healthcare decisions.
Funding
$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many individuals lack a comprehensive understanding of their family health history, hindering their ability to assess their risk for hereditary diseases. Traditional methods of gathering and analyzing this information can be cumbersome and inaccurate, leading to missed opportunities for early detection and preventative care.
Solution
FamGenix provides a suite of tools for both patients and healthcare providers to streamline the collection, analysis, and application of family health history data for hereditary disease risk assessment. The platform offers a patient-facing mobile app that guides users in recording their family's medical history, which can then be shared with clinicians. For providers, FamGenix offers a portal to view auto-generated pedigrees, screen patients based on established guidelines (NCCN/ACMG), and identify individuals who may benefit from genetic counseling or testing. The system also supports integration with existing clinical systems, allowing for seamless incorporation of family health history into patient care workflows and embedded cancer risk models.
Target Audience
The primary target audience includes healthcare providers (physicians, genetic counselors) seeking to improve hereditary disease risk assessment and patients who want to proactively manage their family health history.
Features
- Mobile app for patients to record and manage their family health history
- Provider portal for viewing auto-generated pedigrees and screening patients
- Integration with existing clinical systems via API
- Embedded cancer risk models for assessing lifetime risk
- Patient screening based on NCCN/ACMG guidelines
- Identification of patients who meet criteria for genetic counseling or testing
- Secure data storage and privacy controls
- Customizable platform to fit specific clinical environments